CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.
CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 27, 2012 | Private Equity(PE) | $58M | 1 | — | — | Detail |
Jul 21, 2006 | Series B | $19M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
JP Morgan Chase | — | Private Equity(PE) |
TPG | — | Series B |